Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy Gloria Iacoboni , Josu Iraola-Truchuelo , Alberto Mussetti , Paula Fernandez-Caldas , Victor Navarro Garces , Ana Africa Martin Lopez , Javier Delgado , Ariadna Perez Martinez , Manuel Guerreiro , Ana Carolina Carolina Caballero Gonzalez , Nuria Martinez-Cibrian , Hugo Daniel Luzardo Henriquez , Jose M. Sanchez , Juan-Manuel Sancho , Pere Barba , Mi Kwon , Lucia Lopez Corral , Rafael Hernani , Juan Luis Reguera , Anna Sureda , Alejandro Martin Garcia-Sancho , Mariana Bastos-Oreiro , Pau Abrisqueta BLOOD（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
